Drugs.com - Clinical Trials

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

April 10, 2025 -- Today, the U.S. Food and Drug Administration is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective...

May 12, 2025 - 09:53
 0
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
April 10, 2025 -- Today, the U.S. Food and Drug Administration is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective...
Read More

Tags:

Previous Article

Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In...

Next Article

Tolebrutinib Phase 3 Data Published in NEJM Demonstrate Benefit on Disability Pr...

Related Posts

Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B

Precision BioSciences Receives U.S. FDA Fast Track Desi...

May 12, 2025  0

BlueRock Therapeutics Announces Publication in Nature of 18-Month Data from Phase 1 Clinical Trial for Bemdaneprocel, an Investigational Cell Therapy for Parkinson’s Disease

BlueRock Therapeutics Announces Publication in Nature o...

May 12, 2025  0

BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program

BeiGene Provides Update on the Ociperlimab (BGB-A1217) ...

May 12, 2025  0